Impact News +++ Hugo Boss nimmt für Umbau 2026 Gewinn- und Umsatzrückgang in Kauf (Reuters) +++ HUGO BOSS Aktie -3,14%

COSMO PHARMA Aktie

>COSMO PHARMA Aktienkurs

82 EUR +16.3% (Tradegate)

Ask: 81.5 EUR / 0 Stück

Bid: 81 EUR / 0 Stück

Tagesumsatz: 852 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

COSMO PHARMA Aktie über LYNX handeln

Intraday

1 Jahr

>COSMO PHARMA Performance

1 Woche: -1,4%

1 Monat: -4,8%

3 Monate: +1,5%

6 Monate: +16,8%

1 Jahr: +4,1%

laufendes Jahr: +1,5%

>COSMO PHARMA Aktie

Name:

COSMO PHARMACEUTICALS

Land:

Niederlande

Sektor:

Gesundheit

ISIN/ Wkn:

NL0011832936 / A2AJ68

Symbol/ Ticker:

C43 (Frankfurt)

Kürzel:

FRA:C43, ETR:C43, C43:GR

Index:

Webseite:

https://www.cosmopharma.c..

Profil:

Cosmo Pharmaceuticals N.V. is a specialty pharmace..
>Volltext..

Marktkapitalisierung:

1120.42 Mio. EUR

Unternehmenswert:

1003.29 Mio. EUR

Umsatz:

186.62 Mio. EUR

EBITDA:

66 Mio. EUR

Nettogewinn:

56.6 Mio. EUR

Gewinn je Aktie:

3.53 EUR

Schulden:

2.74 Mio. EUR

Liquide Mittel:

51.47 Mio. EUR

Operativer Cashflow:

64.69 Mio. EUR

Bargeldquote:

2.6

Umsatzwachstum:

-0.51%

Gewinnwachstum:

-19.73%

Dividende je Aktie:

2.05 EUR

Dividendenrendite:

3.08%

Dividendenschätzung:

2.93%

Div. Historie:

04.06.25 - 2.05€
10.07.24 - 2€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

COSMO PHARMA, COSMO PHARMACEUTICALS, COSMO PHARMACEUTICAL

Letzte Datenerhebung:

03.12.25

>COSMO PHARMA Kennzahlen

Aktien/ Unternehmen:

Aktien: 15.94 Mio. St.

Frei handelbar: 44.74%

Leerverk. Aktien: -

Rückkaufquote: 0.62%

Mitarbeiter: 322

Umsatz/Mitarb.: 0.75 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 62.26%

Bewertung:

KGV: 20.8

KGV lG: 6900

KUV: 6.03

KBV: 2.39

PEG-Ratio: -

EV/EBITDA: 15.2

Rentabilität:

Bruttomarge: 73.8%

Gewinnmarge: 30.33%

Operative Marge: 29.2%

Managementeffizenz:

Gesamtkaprendite: 8.8%

Eigenkaprendite: 11.46%

>COSMO PHARMA Peer Group

Es sind 19 Aktien bekannt.

>COSMO PHARMA Chart & Kurs - Tradegate

>COSMO PHARMA News

03.12.25 - 07:18	Cosmo Pharmaceuticals N.V.: Cosmo Announces Breakthrough Phase III Topline Results from Scalp 1 and Scalp 2 for Clascoterone 5% Solution in Male Hair Loss, Showing up to 539% Relative Improvement in Target-Area Hair Count vs Placebo; US and EU Submis (Newsfile)
	Ad hoc announcement pursuant to Art. 53 LR 1,465 patients were randomized into the two identical-in-design clinical studies Scalp 1 (NCT05910450) and Scalp 2 (NCT05914805) Both studies reached sta......

01.12.25 - 15:36	Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe (PR Newswire)
	DUBLIN and MUMBAI, India, Dec. 1, 2025 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) ("Cosmo") and Glenmark Pharmaceuticals Limited (Glenmark), announced that the European Commission (EC) has granted Marketing Authorization (MA) for Winlevi® (clascoterone 10 mg/g cream),......

01.12.25 - 15:33	Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe (PR Newswire)
	DUBLIN and MUMBAI, India, Dec. 1, 2025 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) ("Cosmo") and Glenmark Pharmaceuticals Limited (Glenmark), announced that the European Commission (EC) has granted Marketing Authorization (MA) for Winlevi® (clascoterone 10 mg/g cream),......

14.11.25 - 07:48	Cosmo erhält Zulassung für Aknecreme in Brasilien (Cash)
	Pharma - Cosmo Pharmaceuticals darf seine Aknecreme Winlevi künftig auch in Brasilien verkaufen....

14.11.25 - 07:24	Cosmo Pharmaceuticals N.V.: Winlevi(R) Receives Regulatory Approval in Brazil - Expanding Global Access to a Breakthrough Acne Treatment (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - November 14, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and dermatology innovations, today announced that the Brazil......

11.11.25 - 07:06	Cosmo Pharmaceuticals N.V.: Cosmo′s ESG Rating Upgraded by S&P Global; Strengthens Supplier Sustainability Oversight Engagement, and Italian Manufacturing Plant Awarded EcoVadis Bronze Medal (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - November 11, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced two major milestones ......

03.11.25 - 07:54	Cosmo erhält für KI-Softwareplattform CE-Zertifizierung (Cash)
	Pharma - Cosmo Pharmaceuticals hat für seine KI-Software ColonPRO EU für Koloskopien die CE-Zertifizierung erhalten....

03.11.25 - 07:06	Cosmo Pharmaceuticals N.V.: Cosmo Receives CE Certification for ColonPRO EU - The Most Advanced AI Software Platform for Colonoscopy in Europe (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - November 3, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that ColonPRO EU, the ......

21.10.25 - 07:54	Cosmo erhält EU-Zulassung für Aknecreme Winlevi (Cash)
	Pharma - Cosmo Pharmaceuticals darf seine Akne-Creme Winlevi künftig auch in Europa verkaufen....

21.10.25 - 07:42	Cosmo Pharmaceuticals N.V.: Cosmo Pharmaceuticals Receives Regulatory Approval by the European Commission for Winlevi(R) in the EU, Following on the Positive CHMP Opinion (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - October 21, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that the European Comm......

07.10.25 - 07:18	Cosmo Pharmaceuticals N.V.: Cosmo Pharmaceuticals Announces Regulatory Approval of Winlevi(R) in South Korea (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - October 7, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced that the Minist......

27.08.25 - 08:06	Cosmo erhält nun doch Empfehlung von EU-Ausschuss für Aknemittel (Cash)
	Pharma - Das Spezialitätenpharma-Unternehmen Cosmo hat nach einem ersten Rückschlag nun doch die Empfehlung des EU-Ausschusses für sein Aknemittel Winlevi erhalten....

27.08.25 - 07:18	Cosmo Pharmaceuticals N.V.: Cosmo Receives Positive CHMP Opinion for Winlevi(R) for Treatment of Acne in Adults and Adolescents, Following Successful Re-Examination (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - August 27, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that the European Medic......

26.08.25 - 19:24	Winlevi Acne Cream Secures EU Drug Panel Support in Reversal for Cosmo (Bloomberg)
	Cosmo Pharmaceuticals NV won the backing of European Union regulators for its acne treatment cream, Winlevi, after a surprise initial rejection earlier this year....

08.08.25 - 08:24	Cosmo Pharma Renews Global Manufacturing Deal With Takeda For Ulcerative Colitis Drug (AFX)
	DUBLIN (dpa-AFX) - Cosmo Pharmaceuticals N.V. (COPN.SW) announced the renewal of its multi-year manufacturing and supply agreement with Takeda.As per the deal, Cosmo will continue producing Mesala......

08.08.25 - 08:01	Cosmo und Takeda verlängern strategische Produktionsvereinbarung (Cash)
	Pharma - Cosmo und Takeda verlängern eine Vereinbarung zur Lieferung eines Darmmedikaments....

08.08.25 - 07:30	Cosmo Pharmaceuticals N.V.: Cosmo and Takeda Renew Strategic Manufacturing Agreement for Global Supply of Oral Treatment for Ulcerative Colitis (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - August 8, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced the renewal of i......

06.08.25 - 17:18	Cosmo Pharmaceuticals N.V.: Cosmo Pharmaceuticals Confirms No Exposure to Proposed U.S. Tariffs and Reaffirms Growth Momentum (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - August 6, 2025) - Cosmo Pharmaceuticals N.V. ("Cosmo") notes the recent market volatility following reports on potential U.S. tariffs on Swiss pharmaceutical com......

23.07.25 - 14:30	Cosmo Pharmaceuticals N.V. GAAP EPS of -€0.12, revenue of €51.72M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

23.07.25 - 08:01	Cosmo hebt nach erstem Semester Gewinnprognose an (Cash)
	Pharmaunternehmen - Das Pharmaunternehmen ist im ersten Halbjahr gewachsen und sieht für das Gesamt einen höheren Gewinn als bislang angenommen....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Die deutschen politischen Schriftsteller, nicht an Geist fehlt es ihnen, aber an Mut. - Ludwig Börne

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram